Gossamer Bio

Forecast & Rating7 analysts currently cover Gossamer Bio, with about 42.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $3.86, about 1765.5% upside from the current price of $0.21. Price targets range from $0.28 to $15.00 — a wide spread, showing clear disagreement over just how much Gossamer Bio can rise. For you, this means institutional views on Gossamer Bio are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 28, 2026; for reference only and not investment advice.